Used in the synthesis of antibody-drug conjugates (ADCs) for targeted cancer therapy. The carboxylic acid functional group enables conjugation to antibodies via linker chemistry, allowing precise delivery of cytotoxic agents to tumor cells. Its structure supports improved pharmacokinetics and stability in circulation, enhancing therapeutic efficacy while reducing off-target effects. Commonly applied in oncology research, particularly for hematological malignancies.